Articles

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial

Hospital Universitario de Salamanca-IBSAL, IBMCC (USAL-CSIC), Spain
ICO - Hospital Germans Trias i Pujol, Fundació Josep Carreras, Spain
Hospital Morales Meseguer, Spain
Hospital Universitario La Fe and Universidad Católica de Valencia, Spain
Hospital Universitario Central de Asturias, Spain
Hospital Universitario de Canarias, Spain
Hospital Lozano Blesa de Zaragoza, Spain
Hospital Clínico Universitario de Valencia, Spain
Hospital Universitario Ramón y Cajal de Madrid, Spain
Hospital Universitario Vall de Hebrón de Barcelona, Spain
Hospital Universitario Dr. Peset de Valencia, Spain
Hospital Son Llàtzer de Palma de Mallorca, Spain
Hospital del Mar de Barcelona, Spain
Hospital de la Santa Creu i Sant Pau de Barcelona, Spain
Hospital Universitario de Salamanca-IBSAL, IBMCC (USAL-CSIC), Spain
ICO - Hospital Germans Trias i Pujol, Fundació Josep Carreras, Spain
Clínica Universidad de Navarra-CIMA, Spain
Hospital Universitario de Salamanca-IBSAL, IBMCC (USAL-CSIC), Spain
Vol. 100 No. 9 (2015): September, 2015 https://doi.org/10.3324/haematol.2015.128439